Antibody engineering and production are essential tools in drug discovery, providing powerful and specific therapeutics and diagnostic/prognostic materials for various diseases. Antibodies are ...

Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies.  | The deal allows CSL to ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Recombinant antibody technology has addressed many problems associated with hybridoma-based platforms, opening the door to a new class of biologics. Today, this technology continues to contribute to ...

The hybridoma methodology for developing monoclonal antibodies has been a lab staple for more than 30 years, and it still works great for immunohistochemistry and various cell biology techniques.

Dr. Rob Burgess shares how Sino Biological empowers global biomedical research through precision, quality, and ...

Antibodies are among the most important protein-detecting reagents in research, yet they can be surprisingly unreliable. It’s an issue close to Alejandra Solache’s heart. “The way many antibodies are ...

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies, immunoassay kits, and recombinant proteins, today announced the launch of Multi-rAb Recombinant Secondary Antibodies, the ...

The engineering and production of antibodies are vital in drug discovery, offering effective and precise therapeutics and diagnostic/prognostic materials for numerous diseases. Antibodies are proteins ...

The history of antibody engineering and production in drug discovery can be traced back to the 1970s and 1980s [1] when scientists first began to explore the potential of using antibodies as ...